ASHINGTON — The Obama administration is pledging to finalize revisions to the federal rules governing medical research — despite criticism from scientists and the looming specter of the Trump presidency.

Officials at the Department of Health and Human Services have been working on changes to those regulations, collectively known as the Common Rule, for years now. Parts of the proposal have been vigorously opposed by many researchers, and Republicans in Congress have warned the administration not to finalize any new regulations during the transition to a Donald Trump presidency.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.